Research and Markets (http://www.researchandmarkets.com/reports/c31491) has announced the addition of Protein Kinase Inhibitors in Onoclogy: Drug Pipeline Update 2006 to their
offering.
Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs. However, these three successful
drugs are just the top of an emerging line of therapy. Given the fact that they all target tyrosine kinases and that kinase mutations can cause patients to become resistant to these
drugs, there is plenty of room for more competition. Today, there are more than 100 companies developing more than 180 protein kinase inhibitory drugs in more than 300 clinical trials
targeting around 40 different cancer indications. The number of protein kinase targets has increased to over 50 different molecular targets in just a few years.
How May Drug Pipeline Update Be of Use
Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
Find competitors, collaborations partners, M&A candidates etc.
Jump start competitive drug intelligence operations
Excellent starting point for world wide benchmarking
Compare portfolio and therapy focus with your peers
Speed up pro-active in-/outlicensing strategy work
Fast and easy way of tracking drugs using search engines; just one click and you may search World Wide Web and PubMed for any drug with all its synonyms.
Drug Pipeline Update is Delivered to You as a CD-ROM application
Drug Pipeline Update is fitted into a CD-ROM based application, for your intelligent usage:
Smart CD-ROM application, which makes it easy to use and navigate by
Multiple search and sort functions included
Drug data is linked to search engines like Google and PubMed
Direct links to web pages from inside the application
Found information is easily shared with others over email, file export or in print
System Requirements
AMD-Athlon/Pentium II PC
Windows 98/NT4/2000/ME/XP
8x-speed CD Rom drive
SVGA 16 bit display. (32 bit recommended)
32 MB of available RAM (128 MB recommended)
Internet access (to test web-enabled presentations)
For more information visit http://www.researchandmarkets.com/reports/c31491
Laura Wood
Senior Manager
Research and Markets
email protected from spam bots
Fax: +353 1 4100 980